Study on the impact of patient counseling on the quality of life and pulmonary function of asthmatic patient

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 5, 2012, Pages 300-304

  Mohammed Saji, S ^a   Alhas Ja Jiju, K ^a   Sundaran, Siraj ^a  

^a GULF MEDICAL UNIVERSITY   (United Arab Emirates)

Author keywords

Asthma; Patient counseling; Pulmonary function; Quality of life

Indexed keywords

FLUTICASONE; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INHALER; LUNG FUNCTION; MALE; PATIENT COUNSELING; PRESCRIPTION; QUALITY OF LIFE; SPIROMETRY; UNSPECIFIED SIDE EFFECT;

EID: 84870764101     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Paul O'Byrne, M. D: Global Initiative for Asthma: global strategy for asthma and prevention GINA Workshop Report,2005; 02-3659.
2. World Health Organization. Adherence to long term therapies. Evidence for action, Geneva;2003.
3. Dennis M. Williams. Strategies for optimizing treatment of acute and chronic asthma. Am J Health-Syst Pharm.2006;63(suppl) 3.
4. Rutishauser C, Sawyer, L. Bond S. M, Coffey C, Bowes G. Development and validation of Adolescent Asthma Quality of Life Questionnaire (AAQLQ). Eur Respir J. 2001; 17:52-58.
5. Juniper E.F. Assessing Health Related Quality of Life in asthma. Can Respir J 1997; 4: 145-51.
6. Frode Gallefoss, Per Sigvald Bakke, Pal Kjaersgaard. Quality of Life Assessment after patient Education in a Randomized Controlled study on Asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 812-817.
7. Narayana Mishra, Rao K.V. R, Padhi S.K. Asthma education for better compliance in disease management. Indian J Allergy Asthma Immunol.2005; 19(1):25-28.
8. Barry A, Bunting and Carole, Cranor W. The Asheville Project: Long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006; 46: 133-147.
9. Gallefoss F, Bakke PS. Cost effectiveness of self-management in asthmatics: A one year follow-up randomized, controlled trial. European Respiratory Journal. 2001; 17: 206-213.
10. Thomas Reema, Ramesh Adepu, Thomas Sabin. Impact of clinical pharmacist intervention on knowledge, attitude and practice (kap) of patients with chronic obstructive pulmonary disease. Int J Pharm Pharm Sci, Vol 2, Issue 4, 54-57.
11. Fita Rahmawati, Dewa Putu Pramantara I, Wasilah Rohmah. Polypharmacy and unnecessary drug therapy on geriatric hospitalized patients in yogyakarta hospitals, Indonesia. Int J Pharm Pharm Sci, Vol. 1, Suppl 1, Nov.-Dec. 2009.
12. Stephen P. Peters, Gary Ferguson, Yamo Deniz, Colin Reisner. Uncontrolled asthma: A review of the prevalence, disease burden and option for treatment.J. RMed.2006;100, 1139-1151.
13. Elizabeth F. Juniper, Sonia Buist A. Health-Related Quality of Life in Moderate Asthma: Beclomethasone Dipropionate 400 mg Hydrofluoroalkane Beclomethasone Dipropionate vs 800 mg Chlorofluorocarbon CHEST 1999; 116:1297-1303 50.
14. Dennis Williams. Acute bronchospasm from the patient's perspective: Role of patient education. Pharmacotherapy. 2006; 26(9 Pt 2):193S-199S.
15. Letrait, A. Lurie, K. Bean, M. Mesbah, A. Venot, G. Strauch et al. The Asthma Impact Record (AIR) Index: a rating scale to evaluate the quality of life of asthmatic patients in France. Eur Respir J.1996; 9: 1167-1173.
16. Wang KY, Wu CP, Tang YY, Yang ML. Health related quality of life in Taiwanese patients with bronchial asthma. J Formos Med Assoc, 2004; 103(3): 205-11.
17. Van Schayck CP, Dompeling E, Rutten MP, Folgering H, Van den Boom G, Van Weel C. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995;107:1199-1205.